I am a relatively small pharmaceutical company and want to transform. Do experts in the pharmaceutical industry have any suggestions?

With the aging of the population, the enhancement of residents' health awareness and the implementation of the new medical reform policy, the demand for medicine market continues to grow. Although there are a large number of pharmaceutical enterprises in China, the scale is generally small and intellectual property rights need to be protected. A large number of enterprises mainly manufacture low-end chemical raw materials, with similar drugs, similar properties and insufficient innovation ability. If we are in the transition period, we should make more efforts in technological innovation, develop patented products, open up mature sales channels and improve brand awareness.